Simcere Pharmaceutical Group (NYSE:SCR)
SCR News and Commentary
- Simcere Pharmaceutical Group Increases Sales but Misses Revenue Estimate – The Motley Fool
- BMY Inks Deal with Chinese University - Analyst Blog – NASDAQ
- Simcere Misses on all Fronts - Analyst Blog – NASDAQ
- Cummins Buys SCR Doser Technology - Analyst Blog – NASDAQ
- Delaware Judge Says BofA Can Offer $20 Million Lawsuit Settlement For NY Approval -Bloomberg – SmartMoney
- AGCO Corp. Beats, Ups Guidance - Analyst Blog – NASDAQ
- Don't Get Too Worked Up Over Simcere Pharmaceutical Group's Earnings – The Motley Fool
- Revenues Decline at Simcere Pharma - Analyst Blog – NASDAQ
- Simcere Pharmaceutical Group Crushes Earnings Estimates – The Motley Fool




RSS Headlines
Fool UK